{
    "source": {
        "id": "nbc-news",
        "name": "NBC News"
    },
    "author": "Claire Atkinson",
    "title": "Gilead stock tumbles after remdesivir shows disappointing results in early trial",
    "description": "Stock trading was briefly halted Thursday for California-based Gilead Sciences, after a draft report said its experimental coronavirus treatment disappointed in a recent drug trial.",
    "url": "https://www.nbcnews.com/business/business-news/gilead-stock-falls-after-disappointing-early-trial-results-highly-anticipated-n1190881",
    "urlToImage": "https://media2.s-nbcnews.com/j/newscms/2020_17/3321061/200423-remdesivir-gilead-se-207p_0e673661d53217049d0907f2a74f9814.nbcnews-fp-1200-630.jpg",
    "publishedAt": "2020-04-23T19:02:06Z",
    "content": "Stock trading was briefly halted Thursday for California-based Gilead Sciences, after a draft report said the company's experimental coronavirus treatment disappointed in a recent drug trial.\r\nShares continued to slump, even after the biotech company moved qu\u2026 [+2418 chars]"
}